In the present study, we used the fetal organ culture (FTOC) technique in order to study a putative effect of epidermal growth factor (EGF) on the thymus ontogeny. Functional EGF receptors and more recently the EGF molecule itself, respectively, on the membrane of epithelial components of thymic stroma and on a few thymocytes in adult thymus, had been reported in the literature. We could observe a dose-dependent decrease in cellularity and a progressive retention of thymocytes in the double-negative (CD4-/CD8-) stage of differentiation when exogenous EGF was added. Epidermal growth factor interfered with both fetal stroma growth and thymocyte development at a precise moment, that is, in the passage from double-negative to the double-positive (CD4+/CD8+) stage. After a 7-day FTOC in the presence of EGF, most cells recovered were Thy-l.2+, c-kit+, TSA1 -/int, CD3-, and one of CD44high/CD25 int, CD44-/ CD25int, or CD44-/CD25-. Some developed into y6TCR cells with a mature (CD3+) phenotype, but not into cq3TCR thymocytes. It seems that EGF addition makes the cultures "nonpermissible" for o43TCR thymocyte generation. We report here the presence of a high Mr "EGF-like" molecule on the membrane of fetal thymocytes, which role in the observed effects is under investigation. Further biochemical characterization of this molecule is still required, because its presence was only evidenced on the basis of its antigenicity.
INTRODUCTION
Thymus ontogeny is marked by a sequence of events that lead the precursors derived from fetal liver or bone marrow to a mature T-cell stage (Godfrey and Zlotnik, 1993; Anderson and Perlmutter, 1995) . In the mouse, colonization starts at 10 to 11 days of fetal life (Palacios and Samaridis, 1991) , being succeeded by growth and differentiation of both thymocyte precursors and stromal cells, whose specialization depends on a mutual signaling, in a symbiotic relationship Hollinder et al., 1995) . This cross-talk is mediated by soluble cytokines and hormones, direct contact through membrane *Corresponding author. Present address: Claudia S. Freitas, Instituto Nacional de Cancer, Pesquisa Bsica/6 andar, Praa Cruz Vermelha 23, Rio de Janeiro 20230-130 RJ Brasil. molecules, and extracellular matrix deposition Savino et al., 1993) , and is still poorly understood at least for the initial, pre-T-cell receptor expression stages. Fetal thymus organ cultures (FTOCs) allow these stages to be investigated, because after 7 to 12 days in vitro, starting with 13-to 15-day thymuses, the colonized intact organs develop mimicking almost entirely the in vivo situation up to delivery (Ceredig, 1988) , which occurs around 20 days of fetal life. We used this technique to investigate a possible role for epidermal growth factor (EGF) in the thymus, because functional EGF receptors had been demonstrated on the membrane of the epithelial components of thymic stroma (Le et al., 1991) , and a few cells in the adult thymus were shown by immunohistochemistry to express the EGF molecule itself (Screpanti et al., 1995) .
EGF and its receptor are ubiquitously distributed in mammalian tissues (Carpenter, 1993) . Curiously, they had been reported to be missing in mature hematopoietic cell types (Carpenter, 1993) , until the synthesis and exportation of a member of the family, heparin-binding EGF, was shown in human peripheral blood T lymphocytes (Blotnick et al., 1994) . Soluble EGF is present in many body fluids and produced in large quantities by platelets and submaxillary glands in the adult male mouse, physiologically displaying a circadian variation in submaxillary glands, but not in plasma (Krieger et al., 1976) , where its levels reach a concentration as high as 152 ng/mL after an adrenergic stimulus (Byyni et al., 1974; Grau et al., 1994) . The small peptide, with a Mr of approximately 6000, results from the proteolytic cleavage of a larger membrane complex (Mr 74,000), which consists of two EGF peptides bearing a carboxyl-terminal arginine residue linked to two molecules of EGF-binding protein, an arginin esteropeptidase (Carpenter and Cohen, 1979) . Its precursor, prepro-EGF, has an Mr of approximately 130,000 (Gray et al., 1983) , and in some tissues such as kidneys, it is not cleaved but expressed as a transmembrane integral protein (Rall et al., 1985) , for which a putative receptor function has been suggested (Carpenter, 1993) .
We describe here a blockade of thymocyte growth and differentiation on the addition of exogenous EGF to FTOC, and the presence of a high Mr "EGF-like" molecule on the membrane of fetal thymocytes, which persists in the adult thymus roughly up to the passage to the double-positive CD4+/CD8 stage, suggesting that the EGF system plays a pivotal role in thymus ontogeny at least during these early stages of differentiation.
RESULTS
Effects of Exogenous EGF Addition to Fetal Thymuses In Vitro When 14-day fetal thymuses were exposed to natural murine EGF, a dose-dependent decrease in cellularity and a retention of thymocytes in the double-negative (DN; CD4-/CD8-) stage of differentiation could be observed (Figure 1 ). Such effect depended on the maintenance of EGF throughout the 7 days of culture, because growth and differentiation resumed when EGF was subtracted on day 3 of culture, and stopped when EGF was added on this day to control cultures ( Figure 2A ). The most primitive cells colonizing fetal thymus, however, seemed to survive even to 7 days of culture in the presence of 100 ng/mL EGF, whose subtraction allowed thymocytes to resume their differentiation process ( Figure 2B ), although with a lag phase longer than 1 week. Yet, fully developed FTOC were not seen, with respect to percentages of single-positive subsets, even for longer periods in the absence of EGF.
As reported in the literature, fetal thymocytes can only grow in vitro when the relationship between them and the stromal-cell types is maintained in the intact organ architecture (Watson et al., 1989) . Lobe submersion cultures (LSC), in which the organs are cultured and submerged in medium, result in thymocyte death unless IL-7 and/or IL-2 are added (Watson et al., 1989) . In this case, both cytokines restore growth of the less differentiated thymocyte subpopulations, but cannot restore differentiation up to the double-positive (DP; CD4+/CD8 +) stage (Watson et al., 1989) . In our experiments, the growth of thymocytes in LSC in the presence of IL-2 plus IL-7 was unaffected by EGF (data not shown). The growth of epithelial stromal elements over the substrate, however, was profoundly impaired in the presence of EGF (Figure 3 ). In the case of the EGF-driven blockade of FTOC, even at a suboptimal dose (20 ng/ mL), neither normal growth nor differentiation of thymocytes could be resumed by the addition of IL-2 plus IL-7, and again only the most immature subsets were expanded ( Figure 4A) (Levelt et al., 1993a (Levelt et al., , 1993b Jacobs et al., 1994; Shinkai and Alt, 1994 suggesting that EGF rather interferes with a precise checking point in thymocyte development, affecting both the stromal structure and the thymocyte subsets.
Surface Characteristics of Thymocytes Recovered from a 7-day EGF-FTOC and EGF int ( Figure 7A ), TSA1 -/int (a lymphostromal molecule that was shown to regulate early thymocyte development) (Randle et al., 1993) (Figure 7B ), and some develop into y6TCR thymocytes with a mature phenotype (CD3/, not shown). In fact, it seems that EGF addition makes the culture "nonpermissible" for cffI'CR thymocyte generation ( Figure 7C ).
The cells recovered from 7-day EGF-FTOC (100 ng/ mL EGF) are Thy-l.2 (not shown), the majority being distributed among CD3-/CD44high/CD25int, CD3-/CD44-/CD25int, and CD3-/CD44-/CD25-( Figure 6 ). Most are c-kit (as the most primitive cells colonizing the thymus) (Godfrey and Zlotnik, 1993) FIGURE 3 EGF blocks growth of epithelial cells in explanted fetal thymus lobes. Fourteen-day aged fetal thymus lobes (five to six per plate) were submerged in complete medium in the absence (A) or presence (B) of 100 ng/mL EGF for 20 days. Cultures were then fixed with methanol and immunostained with polyclonal rabbit anti-pan-cytokeratin antiserum followed by FITC-conjugated goat Figure 8A ). Curiously, a less bright pattern of anti-EGF staining (logarithmic scale) was observed for the DN thymocytes recovered from a 7-day EGF-FTOC (100 ng/mL EGF), compared to fresh fetal thymocytes, and that did not seem to accompany the reduction in cell size (linear scale) ( Figure 8B ).
When fetal thymocyte suspensions from 14-and 16-day fetuses were submitted to SDS-PAGE, blotted and revealed with anti-EGF rabbit antiserum followed by PA conjugated anti-rabbit Abs, we could observe a band with an approximate Mr of 120,000 ( Figure 9) which was not present in extracts from other fetal or adult tissues (heart and liver), and could be only observed in adult thymocyte extracts when as many as 10 7 cells were extracted for analysis (not shown).
When the same extracts were run under reducing conditions (/3-mercaptoethanol in the sample buffer) and the blot developed with the same antiserum, the 120,000-Mr band was not observed, nor was it observed when the nonreducing electrophoresis was blotted and developed with normal rabbit serum as control (not shown).
The preceding data suggest that an EGF-like immunoreactive molecule is present on the surface of immature thymocytes and is possibly implicated in the effects observed following exogenous EGF addition.
DISCUSSION
We report here a blockade of fetal thymocyte development in vitro on the addition of exogenous EGF to FTOC. The effect is dose-dependent and requires the constant presence of EGF, a fact that prevents the evaluation of the influence of this factor on each cellular compartment separately, in lobe reconstitution experiments using EGF-preincubated cells, for example. It was apparent, however, that both thymocyte and stromal compartments were affected, possibly at their interaction, because in LSC, the growth of the cytokeratin-positive cell subset was blocked on EGF addition, whereas the growth of immature thymocytes, which depends on IL-2 and/or IL-7 addition and is rather independent of stromal interaction (Watson et al., 1989) , was not affected by EGF (not shown).
With respect to the thymocyte compartment, a blockade in differentiation seemed to occur in FTOC, because the tentative reversal of EGF effects by the addition of IL-2 and IL-7 to FTOC-EGF did in fact expand the immature subset, but could not reverse the retention imposed by this factor in the passage to the DP stage ( Figure 4A ). Figure 5 reinforces (Levelt et al., 1993a (Levelt et al., , 1993b Jacobs et al., 1994; Shinkai and Alt, 1994) Kurt-Jones et al., 1985; Beuscher et al., 1987; Brachman et al., 1989; Wong et al., 1989; Anklesaria et al., 1990; Stein et al., 1990; Teixid6 et al., 1990 Surface characteristics of the thymocytes recovered after 7-day culture in the presence of 100 ng/mL EGF, compared to Control-FTOC thymocytes, 14-day fetal thymocytes, and young adult mouse thymocytes. Double-stainings consisted of anti-c-kit-PE MoAb rabbit anti-EGF antiserum followed by FITC-conjugated goat anti-rabbit IgG Abs, and anti-cq3 TCR-FITC MoAb anti-y6 TCR-biotin
MoAb followed by tricolor-conjugated streptavidin. Anti-TSA1-FITC MoAb single staining is plotted against size (FSC), and each point represents a pool of six, eight, and six lobes, respectively. It should be mentioned that exogenous TGFc (100 ng/mL; human recombinant; Gibco/BRL) did also affect FTOC in a manner similar to that seen with 200 f 14 f 16 FIGURE 9 Presence of a high Mr, anti-EGF immunoreactive molecule in fetal thymocytes. Western blot of 14-day aged (F14) and 16-day aged (F16) fetal thymocytes. Extracts were made using 6 105 cells, which were solubilized and boiled in sample buffer under nonreducing conditions, run on a 7.5% SDS-PAGE, blotted onto nitrocellulose membranes, and developed with anti-EGF antiserum followed by PA-conjugated goat anti-rabbit IgG Abs. (Engel, 1989; Yamada, 1991) , including laminin and tenascin, which are constitutive components of the thymic microenvironment (Savino et al., 1993; Freitas et al., 1995) and have been shown to play important roles in cellular development in other systems (End et al., 1992; Schuppan and Rhl, 1994) , besides modulating T-cell functions (Shimizu et al., 1990; Hemesath et al., 1994) . Also adhesion molecules, such as P-selectin, contain immobilized EGFlike repeats, in this case responsible for leukocyte binding to endothelium (Gibson et al., 1995 The fetal organ cultures were run as described in the literature (Ceredig, 1988) Laemmli and Favre (1973) , under nonreducing conditions. Proteins were transferred in Towbin's buffer containing 0.1% SDS to 0.45-/xm nitrocellulose membranes, which were blocked with 3% BSA in tris-buffered saline, and developed with rabbit polyclonal anti-mouse EGF antiserum, followed by PA-conjugated goat antirabbit IgG Abs, and with the Sigma Fast BCIP/NBT buffered substrate system (0.15 mg/mL 5-bromo-4-chloro-3-indolyl phosphate; 0.30 mg/mL nitro blue tetrazolium; 100 mM Tris; 5 mM MgCI2). Mr standards were Rainbow Coloured Proteins (Amersham, Buckinghamshire, UK).
Immunocytochemistry
Fourteen-day fetal thymus lobes were explanted and cultured for 20 days submerged in complete medium (half volume carefully changed every 3 days) inside 24-well culture plates. The plates were saline-washed, methanol-fixed, and stained with rabbit anti-pancytokeratin antiserum (Dako, Glostrup, Denmark), followed by FITC-conjugated goat anti-rabbit IgG Abs.
